SCHEMBL25646842

SCHEMBL25646842

CNC1COCC12CCNCC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26823091 0.77 — —
SCHEMBL26826635 0.77 — —
SCHEMBL23083759 0.75 SLC6A2 (0.36) —
SCHEMBL28696281 0.74 PTPN11 (0.37) —
SCHEMBL20944889 0.74 PTPN11 (0.37) —
SCHEMBL29715680 0.74 PTPN11 (0.37) —
SCHEMBL29715691 0.74 — —
SCHEMBL20944888 0.74 PTPN11 (0.37) —
SCHEMBL16925303 0.74 PTPN11 (0.37) —
SCHEMBL22050053 0.74 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023104155-A1 LIGAND COMPOUNDS FOR E3 UBIQUITIN LIGASE, PROTEIN DEGRADERS DEVELOPED ON BASIS OF LIGAND COMPOUNDS, AND USES THEREOF 标新生物医药科技(上海)有限公司 2023-06-15 — — WO disclosed
Send feedback